Ralometostat (TNG908) is a potent, selective, and brain-penetrant PRMT5 inhibitor with an IC50 of 4 μM, exerting its effect through an MTA synergistic mechanism. It also demonstrates antitumor activity in xenograft models.
MoreMRTX1719 is a potent and selective inhibitor of the protein arginine methyltransferase 5·methylthioadenosine phosphorylase complex (PRMT5·MTA), which serves as a potential selective therapeutic target for tumor intervention.
MoreOnametostat (JNJ-64619178)是PRMT5抑制剂,具有较高的选择性和效力(PRMT5-MEP-50, IC50=0.14 nM)、良好的药代动力学特性以及安全性
MoreCopanlisib是一个高效的泛I型 PI3K抑制剂,其对PI3Kα/β/γ/δ抑制的IC50分别为0.5, 3.7, 6.4, and 0.7 nM。Phase 3.
MoreTersolisib (STX-478) 是一种高效、突变选择性、变构抑制剂 PI3Kα,可选择性靶向 PI3Kα 的常见突变形式。它对常见的 PI3Kα 螺旋和激酶结构域突变(包括 H1047R 变体)具有很强的疗效,IC50 值为 9.4 nmol/L。与野生型相比,STX-478 对突变型 PI3Kα 的选择性高 14 倍。它可以避免代谢功能障碍并改善 PI3Kα 突变异种移植的治疗反应.
More
